KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Merck (MRK) Receivables - Net (2016 - 2025)

Merck (MRK) has disclosed Receivables - Net for 17 consecutive years, with $11.8 billion as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 14.57% to $11.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $11.8 billion, a 14.57% increase, with the full-year FY2025 number at $11.8 billion, up 14.57% from a year prior.
  • Receivables - Net was $11.8 billion for Q4 2025 at Merck, down from $12.1 billion in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $12.1 billion in Q3 2025 to a low of $7.8 billion in Q2 2021.
  • A 5-year average of $10.3 billion and a median of $10.4 billion in 2023 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: skyrocketed 35.68% in 2021, then decreased 5.07% in 2025.
  • Merck's Receivables - Net stood at $9.2 billion in 2021, then increased by 2.38% to $9.5 billion in 2022, then increased by 9.51% to $10.3 billion in 2023, then fell by 0.69% to $10.3 billion in 2024, then increased by 14.57% to $11.8 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Receivables - Net are $11.8 billion (Q4 2025), $12.1 billion (Q3 2025), and $11.8 billion (Q2 2025).